Role for streptococcal collagen-like protein 1 in M1T1 group A Streptococcus resistance to neutrophil extracellular traps

Infection and Immunity

Volumn 82, Issue 10, 2014, Pages 4011-4020

  Do¨hrmann, Simon ^a   Anik, Sabina ^a   Olson, Joshua ^a   Anderson, Ericka L ^a   Etesami, Neelou ^b   No, Hyewon ^b   Snipper, Joshua ^b   Nizet, Victor ^a,c   Okumura, Cheryl Y M ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b OCCIDENTAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; MEMBRANE PROTEIN; MYELOPEROXIDASE; POLYPEPTIDE ANTIBIOTIC AGENT; STREPTOCOCCAL COLLAGEN LIKE PROTEIN 1; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL INVASION; CLONE; CONTROLLED STUDY; ENZYME RELEASE; EXTRACELLULAR TRAP; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHENOTYPE; PROTEIN DEPLETION; STREPTOCOCCUS GROUP A; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; GENE DELETION; GENETICS; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANIMALS; BACTERIAL ADHESION; CELLS, CULTURED; GENE DELETION; HUMANS; IMMUNE EVASION; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; NEUTROPHILS; PHAGOCYTES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS;

EID: 84907097685     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01921-14     Document Type: Article

References (49)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X.
2. Cole JN, Barnett TC, Nizet V, Walker MJ. 2011. Molecular insight into invasive group A streptococcal disease. Nat. Rev. Microbiol. 9:724-736. http://dx.doi.org/10.1038/nrmicro2648.
3. Papayannopoulos V, Zychlinsky A. 2009. NETs: a new strategy for using old weapons. Trends Immunol. 30:513-521. http://dx.doi.org/10.1016/j.it.2009.07.011.
4. Aziz RK, Kotb M. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis. 14:1511-1517. http://dx.doi.org/10.3201/eid1410.071660.
5. Maamary PG, Ben Zakour NL, Cole JN, Hollands A, Aziz RK, Barnett TC, Cork AJ, Henningham A, Sanderson-Smith M, McArthur JD, Venturini C, Gillen CM, Kirk JK, Johnson DR, Taylor WL, Kaplan EL, Kotb M, Nizet V, Beatson SA, Walker MJ. 2012. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. FASEB J. 26:4675-4684. http://dx.doi.org/10.1096/fj.12-212142.
6. Cole JN, Pence MA, von Ko¨ckritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, Nizet V. 2010. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. mBio 1(4):e00191-10. http://dx.doi.org/10.1128/mBio.00191-10.
7. Zinkernagel AS, Timmer AM, Pence MA, Locke JB, Buchanan JT, Turner CE, Mishalian I, Sriskandan S, Hanski E, Nizet V. 2008. The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe 4:170-178. http://dx.doi.org/10.1016/j.chom.2008.07.002.
8. Pence MA, Rooijakkers SH, Cogen AL, Cole JN, Hollands A, Gallo RL, Nizet V. 2010. Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J. Innate Immun. 2:587-595. http://dx.doi.org/10.1159/000317672.
9. Hollands A, Gonzalez D, Leire E, Donald C, Gallo RL, Sanderson-Smith M, Dorrestein PC, Nizet V. 2012. A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. J. Biol. Chem. 287:40891-40897. http://dx.doi.org/10.1074/jbc.M112.404582.
10. Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, Kotb M, Feramisco J, Nizet V. 2006. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr. Biol. 16:396-400. http://dx.doi.org/10.1016/j.cub.2005.12.039.
11. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, Bailey JR, Parnell MJ, Hoe NP, Adams GG, Deleo FR, Musser JM. 2005. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 102:1679-1684. http://dx.doi.org/10.1073/pnas.0406641102.
12. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. 2006. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2:e5. http://dx.doi.org/10.1371/journal.ppat.0020005.
13. Tsatsaronis JA, Hollands A, Cole JN, Maamary PG, Gillen CM, Ben Zakour NL, Kotb M, Nizet V, Beatson SA, Walker MJ, Sanderson-Smith ML. 2013. Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus. FASEB J. 27:2633-2643. http://dx.doi.org/10.1096/fj.12-226662.
14. Rasmussen M, Ede´n A, Bjo¨rck L. 2000. SclA, a novel collagen-like surface protein of Streptococcus pyogenes. Infect. Immun. 68:6370-6377. http://dx.doi.org/10.1128/IAI.68.11.6370-6377.2000.
15. Lukomski S, Nakashima K, Abdi I, Cipriano VJ, Ireland RM, Reid SD, Adams GG, Musser JM. 2000. Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect. Immun. 68:6542-6553. http://dx.doi.org/10.1128/IAI.68.12.6542-6553.2000.
16. Oliver-Kozup H, Martin KH, Schwegler-Berry D, Green BJ, Betts C, Shinde AV, Van De Water L, Lukomski S. 2013. The group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissue. Mol. Microbiol. 87:672-689. http://dx.doi.org/10.1111/mmi.12125.
17. Oliver-Kozup HA, Elliott M, Bachert BA, Martin KH, Reid SD, Schwegler-Berry DE, Green BJ, Lukomski S. 2011. The streptococcal collagenlike protein-1 (Scl1) is a significant determinant for biofilm formation by group a Streptococcus. BMC Microbiol. 11:262. http://dx.doi.org/10.1186/1471-2180-11-262.
18. Caswell CC, Oliver-Kozup H, Han R, Lukomska E, Lukomski S. 2010. Scl1, the multifunctional adhesin of group A Streptococcus, selectively binds cellular fibronectin and laminin, and mediates pathogen internalization by human cells. FEMS Microbiol. Lett. 303:61-68. http://dx.doi.org/10.1111/j.1574-6968.2009.01864.x.
19. Chen SM, Tsai YS, Wu CM, Liao SK, Wu LC, Chang CS, Liu YH, Tsai PJ. 2010. Streptococcal collagen-like surface protein 1 promotes adhesion to the respiratory epithelial cell.BMCMicrobiol. 10:320. http://dx.doi.org/10.1186/1471-2180-10-320.
20. Caswell CC, Lukomska E, Seo NS, Ho¨o¨k M, Lukomski S. 2007. Scl1-dependent internalization of group A Streptococcus via direct interactions with the α2β1 integrin enhances pathogen survival and re-emergence. Mol. Microbiol. 64:1319-1331. http://dx.doi.org/10.1111/j.1365-2958.2007.05741.x.
21. Han R, Caswell CC, Lukomska E, Keene DR, Pawlowski M, Bujnicki JM, Kim JK, Lukomski S. 2006. Binding of the low-density lipoprotein by streptococcal collagen-like protein Scl1 of Streptococcus pyogenes. Mol. Microbiol. 61:351-367. http://dx.doi.org/10.1111/j.1365-2958.2006.05237.x.
22. Gao Y, Liang C, Zhao R, Lukomski S, Han R. 2010. The Scl1 of M41-type group A Streptococcus binds the high-density lipoprotein. FEMS Microbiol. Lett. 309:55-61. http://dx.doi.org/10.1111/j.1574-6968.2010.02013.x.
23. Humtsoe JO, Kim JK, Xu Y, Keene DR, Ho¨o¨k M, Lukomski S, Wary KK. 2005. A streptococcal collagen-like protein interacts with the α2β1 integrin and induces intracellular signaling. J. Biol. Chem. 280:13848- 13857. http://dx.doi.org/10.1074/jbc.M410605200.
24. Caswell CC, Barczyk M, Keene DR, Lukomska E, Gullberg DE, Lukomski S. 2008. Identification of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins α2β1 and α11β1 J. Biol. Chem. 283:36168-36175. http://dx.doi.org/10.1074/jbc.M806865200.
25. Caswell CC, Han R, Hovis KM, Ciborowski P, Keene DR, Marconi RT, Lukomski S. 2008. The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement. Mol. Microbiol. 67:584-596. http://dx.doi.org/10.1111/j.1365-2958.2007.06067.x.
26. Reuter M, Caswell CC, Lukomski S, Zipfel PF. 2010. Binding of the human complement regulators CFHR1 and factorHby streptococcal collagen-like Protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels. J. Biol. Chem. 285:38473- 38485. http://dx.doi.org/10.1074/jbc.M110.143727.
27. Pa˚hlman LI, Marx PF, Mo¨rgelin M, Lukomski S, Meijers JC, Herwald H. 2007. Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B. J. Biol. Chem. 282:24873-24881. http://dx.doi.org/10.1074/jbc.M610015200.
28. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771. http://dx.doi.org/10.1083/jcb.106.3.761.
29. Kristian SA, Datta V, Weidenmaier C, Kansal R, Fedtke I, Peschel A, Gallo RL, Nizet V. 2005. D-alanylation of teichoic acids promotes group A Streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 187:6719-6725. http://dx.doi.org/10.1128/JB.187.19.6719-6725.2005.
30. Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M. 2000. Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:3523-3534. http://dx.doi.org/10.1128/IAI.68.6.3523-3534.2000.
31. Jeng A, Sakota V, Li Z, Datta V, Beall B, Nizet V. 2003. Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J. Bacteriol. 185: 1208-1217. http://dx.doi.org/10.1128/JB.185.4.1208-1217.2003.
32. Timmer AM, Kristian SA, Datta V, Jeng A, Gillen CM, Walker MJ, Beall B, Nizet V. 2006. Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence. Mol. Microbiol. 62:15-25. http://dx.doi.org/10.1111/j.1365-2958.2006.05337.x.
33. Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. 2007. Optimized Thp-1 differentiation is required for the detection of responses to weak stimuli. Inflamm. Res. 56:45-50. http://dx.doi.org/10.1007/s00011-007 -6115-5.
34. Kuang E, Okumura CY, Sheffy-Levin S, Varsano T, Shu VC, Qi J, Niesman IR, Yang HJ, Lo´pez-Oti´n C, Yang WY, Reed JC, Broday L, Nizet V, Ronai ZA. 2012. Regulation of ATG4B stability by RNF5 limits basal levels of autophagy and influences susceptibility to bacterial infection. PLoS Genet. 8:e1003007. http://dx.doi.org/10.1371/journal.pgen.1003007.
35. von Ko¨ckritz-Blickwede M, Chow O, Ghochani M, Nizet V. 2010. Visualization and functional evaluation of phagocyte extracellular traps. Methods Microbiol. 37:139-160. http://dx.doi.org/10.1016/S0580-9517(10)37007-3.
36. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. 2004. Neutrophil extracellular traps kill bacteria. Science 303:1532-1535. http://dx.doi.org/10.1126/science.1092385.
37. Lauth X, von Ko¨ckritz-Blickwede M, McNamara CW, Myskowski S, Zinkernagel AS, Beall B, Ghosh P, Gallo RL, Nizet V. 2009. M1 protein allows group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J. Innate Immun. 1:202-214. http://dx.doi.org/10.1159/000203645.
38. von Ko¨ckritz-Blickwede M, Nizet V. 2009. Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J. Mol. Med. (Berl.) 87:775-783. http://dx.doi.org/10.1007/s00109-009-0481-0.
39. Vandamme D, Landuyt B, Luyten W, Schoofs L. 2012. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 280:22-35. http://dx.doi.org/10.1016/j.cellimm.2012.11.009.
40. Jann N, Schmaler M, Kristian S, Radek K, Gallo R, Nizet V, Peschel A, Landmann R. 2009. Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trapassociated cathelicidin. J. Leukoc. Biol. 86:1159-1169. http://dx.doi.org/10.1189/jlb.0209053.
41. Chow OA, von Ko¨ckritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, Cogen AL, Gallo RL, Monestier M, Wang Y, Glass CK, Nizet V. 2010. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8:445- 454. http://dx.doi.org/10.1016/j.chom.2010.10.005.
42. Oehmcke S, Mo¨rgelin M, Herwald H. 2009. Activation of the human contact system on neutrophil extracellular traps. J. Innate Immun. 1:225- 230. http://dx.doi.org/10.1159/000203700.
43. Oehmcke S, Shannon O, Mo¨rgelin M, Herwald H. 2010. Streptococcal M proteins and their role as virulence determinants. Clin. Chim. Acta 411:1172-1180. http://dx.doi.org/10.1016/j.cca.2010.04.032.
44. Paterson GK, Nieminen L, Jefferies JM, Mitchell TJ. 2008. PclA, a pneumococcal collagen-like protein with selected strain distribution, contributes to adherence and invasion of host cells. FEMS Microbiol. Lett. 285:170-176. http://dx.doi.org/10.1111/j.1574-6968.2008.01217.x.
45. Bozue J, Moody KL, Cote CK, Stiles BG, Friedlander AM, Welkos SL, Hale ML. 2007. Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages. Infect. Immun. 75:4498-4505. http://dx.doi.org/10.1128/IAI.00434-07.
46. Vandersmissen L, De Buck E, Saels V, Coil DA, Anne´ J. 2010. A Legionella pneumophila collagen-like protein encoded by a gene with a variable number of tandem repeats is involved in the adherence and invasion of host cells. FEMS Microbiol. Lett. 306:168-176. http://dx.doi.org/10.1111/j.1574-6968.2010.01951.x.
47. Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, Varki A. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113:3333-3336. http://dx.doi.org/10.1182/blood-2008-11-187302.
48. A˚kesson P, Rasmussen M, Mascini E, von Pawel-Rammingen E, Janulczyk R, Collin M, Olse´n A, Mattsson E, Olsson ML, Bjo¨rck L, Christensson B. 2004. Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J. Infect. Dis. 189:797-804. http://dx.doi.org/10.1086/381982.
49. Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B. 2005. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variantMsubtypes. Clin. Diagn. Lab. Immunol. 12:833-836. http://dx.doi.org/10.1128/CDLI.12.7.833-836.2005.